Navigation Links
Multi Frequency Finger Grip Intraoperative Transducer UST-8731-7.5

ProductsMulti Frequency Finger Grip Intraoperative Transducer UST-8731-7.5
Company ALOKA, Inc.
Item Multi Frequency Finger Grip Intraoperative Transducer UST-8731-7.5
Features 
  • Can change frequencies on the fly for deeper penetration or for superficial near field resolution
  • Compatible with Aloka Ultrasound Consoles: SSD-4000, Alpha 5
Description The UST-MC11-8731 is a perfect alternative to the UST-995-7.5 for those surgeons who are used to seeing more of a "transverse view in relation to the position of the transducer in the hand.

This is a Super High Density, multi-frequency "T shaped convex intraoperative transducer. The UST-MC11-8731 nestles comfortably between your index and middle fingers so that you can palpate organs while scanning at the same time.

Info ALOKA, Inc.
Customer Service: (800) 872-5652
Web site: http://www.aloka.com

Related medicine products :

1. Black Multi-Pinhole Occluder
2. ReNu MultiPlus Multi-Purpose Solution
3. Renu Multi-Purpose Solution
4. Opti-One Multi-Purpose Solution
5. Solo-Care Brand Multipurpose Solution
6. Renu MultiPlus Multi-Purpose Solution No Rub Formula
7. Renu Multiplus Lubricating and Rewetting Drops
8. Renu Multiplus Multi-Purpose Solution No Rub Formula
9. Multi-Purpose Stand Magnifier
10. Soflens Multi-Focal
11. Frequency 55 Multifocal
... Ultra High Throughput Screening (UHTS), Analyst ... performance. Allows for smooth transfer of ... by sharing all the detection modalities ... intensity, fluorescence polarization, time-resolved fluorescence, luminescence, ...
... OPTIMA is a fully automated microplate ... different measurement principles:, , Fluorescence Polarization ... Fluorescence , High-Performance Luminescence (flash ... ,It is designed for the ...
... From solution to cell based assays, ... any non-isotopic method of detection, Fusion is ... requirements plus the capability to use the ... detection modes in one system: Reads ...
VICTOR2 V measures prompt fluorescence, fluorescence polarization, luminescence, time-resolved fluorescence and absorbance. This model includes high density TRF (for 1536-well plates), temperature ...
Medicine Products:
(Date:7/31/2015)... ... 2015 , ... There’s no better way to enjoy the summer weather than ... the next meal, making July the most appropriate to be National Hot Dog Month. ... , Make the next cookout different than the ones in the past. Celebrate National ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... an important workshop at its new True North Conference Center. The medical community, ... that the Jacksonville community may be more aligned in the effort to better ...
(Date:7/31/2015)... Meadows, IL (PRWEB) , ... July 31, 2015 ... ... ways to communicate. Rally Insurance Group, Inc. has re-branded their social media profiles ... provides a personal way for consumers to communicate, find information, share insights and ...
(Date:7/31/2015)... ... , ... Coco Libre announced today that their flagship Organic Coconut Water will ... US Open of Surfing, July 25 through August 2 in Huntington Beach, California. Coco ... market, is a natural choice given the Open’s commitment to sustainable practices. , ...
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of the Smartest Doc ... Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an ... preparing for the exam easy and painless. MDLinx offers thousands of board-exam style ...
Breaking Medicine News(10 mins):Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3
... Healthy Directions, LLC, is proud to announce the launch of searchjointpain.com, a ... conditions and solutions. , ... Potomac, MD (PRWEB) February 27, 2009 -- ... to announce the launch of searchjointpain.com , a new informational Web ...
... LLC announces the implementation of its rehabilitation software by ... for Southeast Missouri Hospital, a 269-bed regional medical complex ... includes functionality for electronically managing therapy documentation, scheduling, referrals, ... ...
... of the most expensive benefit claims made by members. , ... Melbourne, ... complex bowel surgery heads the annual Medibank Private "Chart Toppers" list of ... of the fund., , ,The bowel surgery claim, costing 20 per cent ...
... Directors Recommends Shareholders Accept the A$318 Million Offer, ... Company Offers Strong Technology Platform and Phase II ... 27 Cephalon, Inc . (Nasdaq: ... subsidiary, Cephalon International Holdings, Inc., intends to make ...
... Asian AffiliateNEW YORK and SINGAPORE, Feb. 26 ... services, has signed an affiliation agreement with Parkway ... based in Singapore and a subsidiary of Parkway ... programs throughout Asia. Under the agreement, ParkwayHealth will ...
... affects approximately 250,000 people in the United States, occurs ... or fatty tissue and loses function. While scientists have ... curing the disease, another part of the mystery has ... University of Missouri scientist and his team have identified ...
Cached Medicine News:Health News:Healthy Living Network Announces Launch of New Joint Pain Web Site 2Health News:Southeast Missouri Hospital Implements Chart Links Rehabilitation Software for Therapists 2Health News:Southeast Missouri Hospital Implements Chart Links Rehabilitation Software for Therapists 3Health News:Health Insurance Claims Top $2 Million Mark 2Health News:Health Insurance Claims Top $2 Million Mark 3Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 2Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 3Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 4Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 5Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 6Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 7Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 8Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 9Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 10Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 11Health News:Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics 12Health News:U.S. Preventive Medicine(R), ParkwayHealth Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services in Asia 2Health News:U.S. Preventive Medicine(R), ParkwayHealth Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services in Asia 3Health News:Muscular dystrophy mystery solved; Mizzou scientist moves closer to MD solution 2
(Date:7/30/2015)... DIEGO , July 30, 2015  Tandem ... medical device company and manufacturer of the t:slim® ... has entered into non-exclusive Development Agreements with Dexcom, ... Tandem insulin pumps with the Dexcom G5 and ... "Integrating Tandem,s next generation pump platform with Dexcom,s ...
(Date:7/30/2015)... July 30, 2015  Amgen (NASDAQ: AMGN ... quarter of 2015. Key results include: , ... quarter of 2014 to $5,370 million, with 6 ... ® (etanercept), Prolia ® (denosumab), Sensipar ... XGEVA ® (denosumab). Unfavorable changes in foreign ...
(Date:7/30/2015)... WOODCLIFF LAKE, N.J. , July 30, 2015 /PRNewswire/ ... submitted simultaneously in the United States ... (to the FDA, EMA and MHLW, respectively) for eribulin, ... sarcoma (STS) who have received prior chemotherapy for advanced ... are based on data from a pivotal global Phase ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5